2014
DOI: 10.9734/bjpr/2014/5350
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous Quantification of Mesalamine and Its Metabolite N-Acetyl Mesalamine in Human Plasma by LC-MS/MS and Its Application to a Bioequivalence Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
2
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 30 publications
1
2
0
Order By: Relevance
“…The detection limits of both analytes at the CNTs-N/GCE are comparable to chromatographic methods reported previously, moreover, the achieved values are better than those reported for HPLC methods with fluorescence [12] and electrochemical detection [15]. Compared with HPLC method coupled to mass spectrometry [17], the LODs obtained with CNTs-N/GCE for both examined analytes were in a higher concentration range. However, the LOQ values obtained at the CNTs-N/GCE as 6.3 and 16.9 ng/mL for 5-ASA and Ac-5-ASA, respectively, are adequate to quantify concentration levels of 5-ASA and its main metabolite generally found in human plasma samples collected during clinical and pharmacokinetic studies in which delay-released formulations are administered at therapeutic dosage.…”
Section: Comparison With Other Analytical Methodssupporting
confidence: 76%
See 1 more Smart Citation
“…The detection limits of both analytes at the CNTs-N/GCE are comparable to chromatographic methods reported previously, moreover, the achieved values are better than those reported for HPLC methods with fluorescence [12] and electrochemical detection [15]. Compared with HPLC method coupled to mass spectrometry [17], the LODs obtained with CNTs-N/GCE for both examined analytes were in a higher concentration range. However, the LOQ values obtained at the CNTs-N/GCE as 6.3 and 16.9 ng/mL for 5-ASA and Ac-5-ASA, respectively, are adequate to quantify concentration levels of 5-ASA and its main metabolite generally found in human plasma samples collected during clinical and pharmacokinetic studies in which delay-released formulations are administered at therapeutic dosage.…”
Section: Comparison With Other Analytical Methodssupporting
confidence: 76%
“…At present, several HPLC methods with a fluorescence [11][12][13], electrochemical [14,15] and mass spectrometry detection [16,17] were developed for simultaneous quantification of 5-ASA and its N-acetylated metabolite. The satisfactory results were obtained with excellent selectivity and low detection limit.…”
Section: Introductionmentioning
confidence: 99%
“…[11][12][13][14][15] The drug was also determined by different UV-spectrophotometric, 16) and Vireodt's method. 17) Spectrofluorimetric, 18,19) TLC, 20,21) HPLC, [22][23][24][25] ultra performance liquid chromatography (UPLC) 26,27) and LC-MS 28) were reported for analysis of ME either in single or in combination with other drugs. Only one HPTLC method was published for determination of ME and its degradation products that depended on using toluene-methanol-ethyl acetate (6.5 : 2.5 : 1, v/v/v) as a developing system and scanning at 244 nm.…”
mentioning
confidence: 99%